Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Medication Guide

Ketamine

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Rx required Liquid (Solution) Multiple FDA sponsors Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Jun 22, 2026, 10:40 a.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
Jun 22, 2026, 10:40 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
Jun 22, 2026, 10:42 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Jun 22, 2026, 10:40 AM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Jun 22, 2026, 10:40 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Image coming soon
Ketamine

Ketamine

Drug type: Generic ingredient • Generic profile • No FDA branded products linked

Both Liquid (Solution) Rx required 100% reference complete

Species: Both

Manufacturer: Multiple FDA sponsors

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Ketamine

It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation. It is used for restraint. It is used in cats as the sole anesthetic agent for ovariohysterectomy and general surgery. Species commonly shown: Both, Cat, Primates, Non-Human Primates.

Generic name
Ketamine
Brand names
Ketamine Hydrochloride Injection, Ketamine Hydrochloride Injection, USP, VetaKet®, Ketamine HCL
Manufacturer
Multiple FDA sponsors
Species
Both, Cat, Primates
Dosage forms
Liquid (Solution)
Prescription
Prescription required
Completeness
100%
Validation
Needs review
Brand names
Ketamine Hydrochloride Injection Ketamine Hydrochloride Injection, USP VetaKet® Ketamine HCL KetaFlo™
Dosage forms
Liquid (Solution)

Indications / Uses

It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation. It is used for restraint. It is used in cats as the sole anesthetic agent for ovariohysterectomy and general surgery.

Warnings / Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Side Effects

Top reported reactions (openFDA): Vomiting, Death, Lack of efficacy - NOS, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurological'), Bradycardia.

FAQ

Both, Cat, Primates, Non-Human Primates, Cat, Restricted During Pregnancy

Yes. Roxee shows this as prescription-only.

Liquid (Solution)

Source Transparency

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

It is used for restraint.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Store in a cool place
  • Protect from light
  • Do not use if precipitate appears
  • Vomiting (1 reports)
  • wobbly/unsteady walking (1 reports)
  • trouble breathing (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Facial swelling or hives.
  • Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence
Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Ketamine; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case DEU-USFDACVM-2025-DE-000039
Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 22 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case DEU-USFDACVM-2025-DE-000039
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case DEU-USFDACVM-2025-DE-000039
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Vomiting (1 reports), Unsteady walking (ataxia) (1 reports), Trouble breathing (dyspnea) (1 reports), Faint heart sound (1 reports), Facial swelling (possible allergy) (1 reports)

Body systems represented Signal grouping

Digestive (4), Skin & allergy (2), Neurologic (2), Behavior (2)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Cat (19 reports), Dog (13 reports)

Breed metadata in reports Metadata only

Domestic Shorthair (3), ['Retriever - Golden', 'Poodle - Standard'] (2), Greyhound (1), Crossbred Canine/dog (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Ketamine fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Store in a cool place, Protect from light, Do not use if precipitate appears, Vomiting, wobbly/unsteady walking

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Ketamine brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA case DEU-USFDACVM-2025-DE-000039 · adverse_reaction · adverse reactions
  2. Contraindication source · fda_animal_drugs · warnings contraindications
  3. FDA application profile · official_label · quick facts
  4. FDA application profile · official_label · quick facts
  5. Medication usage source · fda_animal_drugs · quick facts
  6. FOI · document · documents
  7. SPL · document · documents
  8. FOI · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: April 15, 2026, 10:04 AM UTC

Sources:
Safety & side effects

Side effects to monitor:

  • Store in a cool place
  • Protect from light
  • Do not use if precipitate appears
  • Vomiting
  • wobbly/unsteady walking

Most reported reactions:

  • Vomiting (1 reports)
  • Unsteady walking (ataxia) (1 reports)
  • Trouble breathing (dyspnea) (1 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Facial swelling or hives.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Cat, Primates
Indication / use
It is used for restraint.
Form / route / dose
Form: Liquid (Solution)
Route: Intramuscular
Confirm product label and patient-specific plan.
Warnings
  • High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect fr…
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA sponsors
Form: Liquid (Solution)
Identifiers:
ANADA: 200029 ANADA: 200042 ANADA: 200055 ANADA: 200073 ANADA: 200257 ANADA: 200279 NADA: 45290 NADA: 92116 NDC Package: 11695-0703-1 NDC Package: 11695-7039-1 NDC Package: 13985-584-10 NDC Package: 17033-101-10 NDC Package: 54771-2013-1 NDC Package: 69043-063-01 NDC Package: 86136-144-31 NDC Product: 11695 NDC Product: 13985 NDC Product: 17033 NDC Product: 54771 NDC Product: 69043
Source metadata:

Warnings / Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
25
Matching reports
25
Active filters
0
Reset
Drill into common report signals
Lack of efficacy - NOS (5) Not eating (5) Death (3) Intentional misuse (3) Other (23) Effectiveness (6) Neurologic (6) Skin & allergy (5)
Showing up to 50 matching reports.

USA-USFDACVM-2025-US-075461

Received 2025-12-29 · MSK · MSK

Serious
Species
Dog
Breed
Greyhound
Size / weight
50-99 lb (27.3 Kilogram)
Age
8+ years (9 Year)
Sex
Female Neutered
Region
USA
Reactions
Lack of efficacy - NOSUnrelated death
Body systems
EffectivenessOther
Outcomes
Euthanized

USA-USFDACVM-2025-US-075440

Received 2025-12-29 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Golden', 'Poodle - Standard']
Size / weight
50-99 lb (25.5 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy - NOSUnrelated death
Body systems
EffectivenessOther
Outcomes
Euthanized

USA-USFDACVM-2025-US-075367

Received 2025-12-29 · MSK · MSK

Serious
Species
Dog
Breed
Crossbred Canine/dog
Size / weight
25-49 lb (17.7 Kilogram)
Age
8+ years (14 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy - NOSUnrelated death
Body systems
EffectivenessOther
Outcomes
Euthanized

USA-USFDACVM-2025-US-074179

Received 2025-12-18 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.084 Kilogram)
Age
Under 1 year (6 Month)
Sex
Female Intact
Region
USA
Reactions
Elevated temperatureBreathing difficultyQuiet
Body systems
Other
Outcomes
Ongoing

USA-USFDACVM-2025-US-074533

Received 2025-12-17 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (2.5 Kilogram)
Age
Under 1 year (4 Month)
Sex
Female Neutered
Region
USA
Reactions
HypersalivationTachypnoeaAbnormal radiograph findingHypothermiaHyperactivityNot eatingLethargy (see also Central nervous system depression in Neurological)Hiding
Body systems
DigestiveOtherNeurologic
Outcomes
Ongoing

USA-USFDACVM-2025-US-074366

Received 2025-12-17 · MSK · MSK

Non-serious
Species
Dog
Breed
Coton de Tuléar
Size / weight
Under 10 lb (3.719 Kilogram)
Age
4-7 years (4 Year)
Sex
Female Unknown
Region
USA
Reactions
Lack of efficacy - NOSVomitingIntentional misuse
Body systems
EffectivenessDigestiveOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-073634

Received 2025-12-17 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.62 Kilogram)
Age
Under 1 year (5 Month)
Sex
Male Neutered
Region
USA
Reactions
Seizure NOSAgitation
Body systems
NeurologicOther
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-074431

Received 2025-12-16 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Golden', 'Poodle - Standard']
Size / weight
50-99 lb (43.273 Kilogram)
Age
4-7 years (7 Year)
Sex
Male Neutered
Region
USA
Reactions
ThrombocytopeniaBlood loss NOSSkin petechiaeDeath
Body systems
Other
Outcomes
Died

USA-USFDACVM-2025-US-073842

Received 2025-12-15 · MSK · MSK

Non-serious
Species
Cat
Breed
Maine Coon
Size / weight
10-24 lb (6.1 Kilogram)
Age
Under 1 year (7 Month)
Sex
Male Intact
Region
USA
Reactions
Not eatingNot sleepingStaringFalling
Body systems
Other
Outcomes
Recovered/Normal

USA-USFDACVM-2025-US-074903

Received 2025-12-12 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (4.354 Kilogram)
Age
1-3 years (12 Month)
Sex
Male Intact
Region
USA
Reactions
Local swelling (not application site)Death
Body systems
Skin & allergyOther
Outcomes
Died

USA-USFDACVM-2025-US-074118

Received 2025-12-11 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Golden', 'Poodle (unspecified)']
Size / weight
25-49 lb (16.329 Kilogram)
Age
Under 1 year (7 Month)
Sex
Female Unknown
Region
USA
Reactions
Intestinal perforationPeritonitisFeverDiarrhoeaNot eating
Body systems
OtherDigestive
Outcomes
Ongoing

USA-USFDACVM-2025-US-072426

Received 2025-12-10 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (5.81 Kilogram)
Age
8+ years (9 Year)
Sex
Male Neutered
Region
USA
Reactions
Application site alopecia
Body systems
Skin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-072148

Received 2025-12-10 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.175 Kilogram)
Age
Under 1 year (8 Month)
Sex
Female Intact
Region
USA
Reactions
Faint heart soundCardiac arrestIntentional misuseDeath
Body systems
Other
Outcomes
Died

USA-USFDACVM-2025-US-074439

Received 2025-12-09 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Golden', 'Poodle - Standard']
Size / weight
100+ lb (46 Kilogram)
Age
8+ years (8 Year)
Sex
Male Intact
Region
USA
Reactions
Seizure NOSRough recovery
Body systems
NeurologicOther
Outcomes
Recovered/Normal

USA-USFDACVM-2025-US-074438

Received 2025-12-09 · MSK · MSK

Serious
Species
Dog
Breed
['Siberian Husky', 'Dog (unknown)']
Size / weight
100+ lb (46 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
Seizure NOSRecovery prolonged
Body systems
NeurologicOther
Outcomes
Recovered/Normal

USA-USFDACVM-2025-US-073513

Received 2025-12-09 · MSK · MSK

Non-serious
Species
Dog
Breed
['Pointing Dog - Hungarian Short-haired (Vizsla)', 'Retriever - Labrador']
Size / weight
50-99 lb (40.415 Kilogram)
Age
8+ years (8 Year)
Sex
Male Neutered
Region
USA
Reactions
Application site scarInjection site alopeciaInjection site reaction NOSInjection site noduleMast cell tumourLack of efficacy (neoplasia, relapse)
Body systems
OtherSkin & allergyEffectiveness
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-073350

Received 2025-12-04 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic (unspecified)
Size / weight
10-24 lb (5.9 Kilogram)
Age
1-3 years (3.67 Year)
Sex
Male Intact
Region
USA
Reactions
AgitationDecreased pulse oxygenationIncreased respiratory rateHyperthermiaHyperactivity
Body systems
Other
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-072431

Received 2025-12-04 · MSK · MSK

Non-serious
Species
Cat
Breed
Cat (unknown)
Size / weight
Under 10 lb (1.81 Kilogram)
Age
4-7 years (4 Year)
Sex
Male Neutered
Region
USA
Reactions
DepressionBehavioural disorder NOSLow creatinineHypoproteinaemiaElevated blood urea nitrogen (BUN)HypoglycaemiaHypoalbuminaemiaReduced globulinsElevated alanine aminotransferase (ALT)Low serum alkaline phosphatase (ALP)Decreased body temperature
Body systems
NeurologicBehaviorOther
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-072415

Received 2025-12-04 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic (unspecified)
Size / weight
Under 10 lb (3.86 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Intact
Region
USA
Reactions
DysphoriaElevated temperature
Body systems
Other
Outcomes
Ongoing

USA-USFDACVM-2025-US-071193

Received 2025-12-04 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.65 Kilogram)
Age
8+ years (14 Year)
Sex
Female Neutered
Region
USA
Reactions
Application site alopeciaWobblinessNot eating
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-071320

Received 2025-12-03 · MSK · MSK

Non-serious
Species
Cat
Breed
Cat (unknown)
Sex
Unknown Unknown
Region
USA
Reactions
Lack of efficacy - NOS
Body systems
Effectiveness
Outcomes
Recovered/Normal

USA-USFDACVM-2025-US-071903

Received 2025-12-02 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (4.99 Kilogram)
Age
8+ years (1 Year)
Sex
Female Unknown
Region
USA
Reactions
Injection site hair lossPapuleInjection site itching
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-069797

Received 2025-11-24 · MSK · MSK

Non-serious
Species
Dog
Breed
['Mastiff (unspecified)', 'Dog (unknown)']
Size / weight
50-99 lb (35.834 Kilogram)
Age
1-3 years (3 Year)
Sex
Female Unknown
Region
USA
Reactions
Urinary incontinence
Body systems
Other
Outcomes
Ongoing

USA-USFDACVM-2025-US-067000

Received 2025-11-14 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (3.992 Kilogram)
Age
8+ years (13 Year)
Sex
Female Unknown
Region
USA
Reactions
DiarrhoeaDecreased appetiteLethargy (see also Central nervous system depression in Neurological)Bloody diarrhoeaDry mucous membraneOpen mouth breathingUnresponsive to stimuliDecreased haematocritIncreased percentage reticulocytesRegenerative anaemiaIntentional misuseUnderdoseThrombocytopeniaHeart murmurHypersalivation
Body systems
DigestiveNeurologicOther
Outcomes
Ongoing

USA-USFDACVM-2025-US-065439

Received 2025-11-04 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Labrador', 'Dog (unknown)']
Size / weight
25-49 lb (18.144 Kilogram)
Age
1-3 years (3 Year)
Sex
Female Unknown
Region
USA
Reactions
VocalisationPain NOSLimb non-weight bearingNot eatingNot drinkingBiting -aggression (see also Skin and appendages disorders)Stiffness NOSReluctant to moveAbnormal posture NOS
Body systems
OtherBehavior
Outcomes
Ongoing

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
22
Species represented
2
Grouped by Body System
Digestive (4) · Vomiting, Diarrhea, Decreased appetite Skin & allergy (2) · Hair loss at application site, Facial swelling (possible allergy) Neurologic (2) · Unsteady walking (ataxia), Depression Behavior (2) · Biting -aggression, Behavioral disorder (unspecified) Other (22) · Trouble breathing (dyspnea), Faint heart sound, Elevated temperature
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Digestive 1 Dog 1
Neurologic 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Skin & allergy 1 Dog 1
Other 1 Cat 1
Digestive 1 Cat 1
Other 1 Cat 1

Species coverage: Cat (19) Dog (13)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Digestive Dog Serious - 1
Neurologic Dog Serious - 1
Other Dog Serious - 1
Skin & allergy Cat Non-serious - 1
Other Cat Serious - 1
Skin & allergy Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Digestive Cat Serious - 1
Neurologic Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Cat Non-serious - 1
Digestive Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Digestive Cat Serious - 1
Other Dog Serious - 1
Behavior Dog Serious - 1
Behavior Dog Serious - 1
Other Dog Non-serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Source metadata:

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Ketamine HCL SPL · SPL VetaKet® SPL · SPL Ketamine Hydrochloride Injection SPL · SPL

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

6

FOI

6

Ketamine HCL

SPL · SPL

Open original
FDA Structured Product Label

Ketamine HCL

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Mylan Institutional LLC, a Viatris Company
ANADA
200-257
Status
RX
Form
Liquid (Solution)
Route
Intramuscular
Species
Primates • Cat
Composition / specifications
Each milliliter contains ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.

Subhuman primates

Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

VetaKet®

SPL · SPL

Open original
FDA Structured Product Label

VetaKet®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Cronus Pharma Specialities India Private Ltd.
ANADA
200-055
Status
RX
Form
Liquid (Solution)
Route
Intramuscular
Species
Primates • Cat
Composition / specifications
The drug is a sterile aqueous solution and each milliliter contains: Ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.

Cats

Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.

Subhuman primates

Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.

Ketamine Hydrochloride Injection

SPL · SPL

Open original
FDA Structured Product Label

Ketamine Hydrochloride Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Cronus Pharma Specialities India Private Ltd.
ANADA
200-029
Status
RX
Form
Liquid (Solution)
Route
Intramuscular
Species
Cat
Composition / specifications
The drug is a sterile aqueous solution and each milliliter contains: Ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.

Cats

Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.

Ketamine Hydrochloride Injection, USP

SPL · SPL

Open original
FDA Structured Product Label

Ketamine Hydrochloride Injection, USP

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Elanco US Inc.
ANADA
200-042
Status
RX
Form
Liquid (Solution)
Route
Intramuscular
Species
Primates • Cat
Composition / specifications
Each milliliter contains ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.

Subhuman primates

Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Ketamine Hydrochloride Injection, USP

SPL · SPL

Open original
FDA Structured Product Label

Ketamine Hydrochloride Injection, USP

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Dechra Veterinary Products LLC
ANADA
200-073
Status
RX
Form
Liquid (Solution)
Route
Intramuscular
Species
Primates • Cat
Composition / specifications
The drug is a sterile aqueous solution and each milliliter contains: Ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.

Cats

Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.

Subhuman primates

Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.

KetaFlo™

SPL · SPL

Open original
FDA Structured Product Label

KetaFlo™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Abbott Laboratories
ANADA
200-279
Status
RX
Form
Liquid (Solution)
Route
Intramuscular
Species
Primates • Cat
Composition / specifications
The drug is a sterile aqueous solution and each milliliter contains: Ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.

Cats

Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Subhuman primates

Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

ucm061682.pdf

FOI · FOI

Open original

A200055_Orig_08_03_1998.pdf

FOI · FOI

Open original

A200029_Org_8_16_1995.pdf

FOI · FOI

Open original

A200042_Orig_06_30_1994.pdf

FOI · FOI

Open original

A200073_Org_7_21_1994.pdf

FOI · FOI

Open original

ucm061704.pdf

FOI · FOI

Open original
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Jun 22, 2026, 10:40 AM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Jun 22, 2026, 10:40 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Official (FDA)
Identity: Generic ingredient • No FDA branded products linked
No official FDA brand rows linked yet for this ingredient.
Case-reported brands (openFDA): MSK
Catalog species: Both • FDA-labeled species: Cat, Primates
Rx/OTC: RX
Form/route: Liquid (Solution) • Intramuscular
Applications: ANADA 200-257 • ANADA 200-055 • ANADA 200-029 • ANADA 200-042 • ANADA 200-073 • ANADA 200-279
Documents: 6 (FOI: 6) • SPL: 6 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 31 • Cat 54 • View
Case summaries: 25 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Top reaction signals
Vomiting (1) Unsteady walking (ataxia) (1) Trouble breathing (dyspnea) (1) Faint heart sound (1) Facial swelling (possible allergy) (1) Dry mucous membrane (1) Diarrhea (1) Decreased haematocrit (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200029 ANADA: 200042 ANADA: 200055 ANADA: 200073 ANADA: 200257 ANADA: 200279 NADA: 45290 NADA: 92116 NDC Package: 11695-0703-1 NDC Package: 11695-7039-1 NDC Package: 13985-584-10 NDC Package: 17033-101-10 NDC Package: 54771-2013-1 NDC Package: 69043-063-01 NDC Package: 86136-144-31 NDC Product: 11695 NDC Product: 13985 NDC Product: 17033 NDC Product: 54771 NDC Product: 69043 NDC Product: 86136
Package NDC Product NDC Form / Route Status
11695-0703-1 11695 -
11695-7039-1 11695 -
13985-584-10 13985 -
17033-101-10 17033 -
54771-2013-1 54771 -
69043-063-01 69043 -
86136-144-31 86136 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 16 Clinical 9 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appe… (Clinical, 2026-04-15)
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appe… (Clinical, 2026-04-15)
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appe… (Clinical, 2026-04-11)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-15)
  • side_effects: Top reported reactions (openFDA): Vomiting, Death, Lack of efficacy - NOS, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurol… (Clinical, 2026-04-11)
  • usage: It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation. It i… (Clinical, 2026-04-15)
  • usage: It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation. It i… (Clinical, 2026-04-15)
  • usage: It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation. It i… (Clinical, 2026-04-11)
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appe… (Official, 2026-04-22)
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appe… (Official, 2026-02-12)
  • side_effects: Top reported reactions (openFDA): Vomiting, Death, Lack of efficacy - NOS, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurol… (Official, 2026-04-22)
  • side_effects: Top reported reactions (openFDA): Vomiting, Death, Lack of efficacy - NOS, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurol… (Official, 2026-04-15)
  • side_effects: Top reported reactions (openFDA): Vomiting, Death, Lack of efficacy - NOS, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurol… (Official, 2026-04-15)
  • side_effects: Top reported reactions (openFDA): Vomiting, Death, Lack of efficacy - NOS, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurol… (Official, 2026-02-12)
  • usage: It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation. It i… (Official, 2026-04-22)
  • usage: Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus. (Official, 2026-04-16)
  • usage: Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus. (Official, 2026-04-15)
  • usage: It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation. It i… (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • monitoring updated 2026-04-16 13:28 by curated_loader • Clinical monitoring context for feline diabetes management.
  • usage updated 2026-04-16 13:28 by curated_loader • Usage statement from FDA warning letter and approved-product context.
  • drug_profile_type updated 2026-04-16 13:28 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
  • manufacturer_name updated 2026-04-16 13:28 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
  • brand_names updated 2026-04-16 13:28 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
  • approval_reference updated 2026-04-16 13:28 by curated_loader • Official FDA application reference for Senvelgo.
  • side_effects updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
  • monitoring updated 2026-04-15 10:07 by curated_loader • Clinical monitoring context for feline diabetes management.
  • usage updated 2026-04-15 10:07 by curated_loader • Usage statement from FDA warning letter and approved-product context.
  • drug_profile_type updated 2026-04-15 10:07 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
  • manufacturer_name updated 2026-04-15 10:07 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
  • brand_names updated 2026-04-15 10:07 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
  • approval_reference updated 2026-04-15 10:07 by curated_loader • Official FDA application reference for Senvelgo.
  • side_effects updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Ketamine HCL
RX
Ketamine Hydrochloride
Liquid (Solution) • Intramuscular
Label highlights
Official documents
Mylan Institutional LLC, a Viatris Company ANADA 200-257 W Jan 21, 2025
VetaKet®
RX
Ketamine Hydrochloride
Liquid (Solution) • Intramuscular
Label highlights
Official documents
Cronus Pharma Specialities India Private Ltd. ANADA 200-055 Approved Jun 13, 2024
Ketamine Hydrochloride Injection
RX
Ketamine Hydrochloride
Liquid (Solution) • Intramuscular
Label highlights
Official documents
Cronus Pharma Specialities India Private Ltd. ANADA 200-029 Approved Feb 1, 2018
Ketamine Hydrochloride Injection, USP
RX
Ketamine Hydrochloride
Liquid (Solution) • Intramuscular
Label highlights
Official documents
Elanco US Inc. ANADA 200-042 Approved Aug 4, 2017
Ketamine Hydrochloride Injection, USP
RX
Ketamine Hydrochloride
Liquid (Solution) • Intramuscular
Label highlights
Official documents
Dechra Veterinary Products LLC ANADA 200-073 Approved May 19, 2017
KetaFlo™
RX
Ketamine Hydrochloride
Liquid (Solution) • Intramuscular
Label highlights
Official documents
Abbott Laboratories ANADA 200-279 W Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Primates • Cat
Composition / specifications
Each milliliter contains ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.
Subhuman primates
Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Primates • Cat
Composition / specifications
The drug is a sterile aqueous solution and each milliliter contains: Ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.
Cats
Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.
Subhuman primates
Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.

FDA page: Open in Animal Drugs @ FDA

Species: Cat
Composition / specifications
The drug is a sterile aqueous solution and each milliliter contains: Ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.
Cats
Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.

FDA page: Open in Animal Drugs @ FDA

Species: Primates • Cat
Composition / specifications
Each milliliter contains ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.
Subhuman primates
Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Primates • Cat
Composition / specifications
The drug is a sterile aqueous solution and each milliliter contains: Ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.
Cats
Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.
Subhuman primates
Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears.

FDA page: Open in Animal Drugs @ FDA

Species: Primates • Cat
Composition / specifications
The drug is a sterile aqueous solution and each milliliter contains: Ketamine hydrochloride equivalent to 100 milligrams ketamine base activity.
Cats
Indication
It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 5 to 15 milligrams per pound of body weight depending on the effect desired.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Subhuman primates
Indication
It is used for restraint.
Dosage
It is administered intramuscularly at a recommended dose that ranges from 3 to 15 milligrams per kilogram of body weight depending upon the species, general condition and age of the subject.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Usage

It is used for restraint or as the sole anesthetic agent in diagnostic or minor, brief surgical procedures that do not require skeletal muscle relaxation. It is used for restraint. It is used in cats as the sole anesthetic agent for ovariohysterectomy and general surgery.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Store in a cool place. Protect from light. Do not use if precipitate appears. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Vomiting (1) • Dog Diarrhea (1) • Cat Decreased appetite (1) • Cat Bloody diarrhoea (1) • Cat

Showing top 5 for Digestive.

Skin & allergy
Hair loss at application site (1) • Cat Facial swelling (possible allergy) (1) • Dog

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Dog Depression (1) • Cat

Showing top 5 for Neurologic.

Behavior
Biting -aggression (1) • Dog Behavioral disorder (1) • Dog

Showing top 5 for Behavior.

Other
Trouble breathing (1) • Dog Faint heart sound (1) • Cat Elevated temperature (1) • Cat Elevated blood urea nitrogen (1) • Cat Elevated alanine aminotransferase (1) • Cat
Show more (17)
Dysphoria (1) • Cat Dry mucous membrane (1) • Cat Decreased pulse oxygenation (1) • Cat Decreased haematocrit (1) • Cat Decreased body temperature (1) • Cat Death by euthanasia (1) • Cat Death (1) • Dog Cognitive disorder NOS (1) • Dog Cardiac arrest (1) • Cat Breathing difficulty (1) • Cat Blood loss NOS (1) • Dog Application site scar (1) • Dog Agitation (1) • Cat Abnormal ultrasound finding (1) • Dog Abnormal radiograph finding (1) • Cat Abnormal posture NOS (1) • Dog Abdominal pain (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Greyhound, Female, 9 year, 27.3 kilogram • Drug: MSK, Subcutaneous • Reactions: Lack of efficacy - NOS, Unrelated death • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-075461
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 9.00 Year
  • Weight: 27.300 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
Reactions Reported:
Lack of efficacy - NOS Unrelated death
Outcomes: Euthanized

Dog, ['Retriever - Golden', 'Poodle - Standard'], Male, 5 year, 25.5 kilogram • Drug: MSK, Subcutaneous • Reactions: Lack of efficacy - NOS, Unrelated death • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-075440
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.00 Year
  • Weight: 25.500 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
Reactions Reported:
Lack of efficacy - NOS Unrelated death
Outcomes: Euthanized

Dog, Crossbred Canine/dog, Male, 14 year, 17.7 kilogram • Drug: MSK, Subcutaneous • Reactions: Lack of efficacy - NOS, Unrelated death • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-075367
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 14.00 Year
  • Weight: 17.700 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
Reactions Reported:
Lack of efficacy - NOS Unrelated death
Outcomes: Euthanized

Cat, Domestic Shorthair, Female, 6 month, 3.084 kilogram • Drug: MSK, Unknown, Dose: 0.70 Milligram per animal • Reactions: Elevated temperature, Breathing difficulty, Quiet • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074179
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 6.00 Month
  • Weight: 3.084 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Dose: 0.70 Milligram per animal
Reactions Reported:
Elevated temperature Breathing difficulty Quiet
Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 4 month, 2.5 kilogram • Drug: MSK, Injection, solution, Unknown • Reactions: Drooling, Tachypnoea, Abnormal radiograph finding, Hypothermia, Hyperactivity… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074533
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 4.00 Month
  • Weight: 2.500 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Injection, solution
Reactions Reported:
Drooling Tachypnoea Abnormal radiograph finding Hypothermia Hyperactivity Not eating Tiredness (lethargy) Hiding
Outcomes: Ongoing

Dog, Coton de Tuléar, Female, 4 year, 3.719 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Lack of efficacy - NOS, Vomiting, Intentional misuse • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074366
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 4.00 Year
  • Weight: 3.719 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Lack of efficacy - NOS Vomiting Intentional misuse
Outcomes: Ongoing

Cat, Domestic Shorthair, Male, 5 month, 3.62 kilogram • Drug: MSK, Intravenous • Reactions: Seizure NOS, Agitation • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-073634
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.00 Month
  • Weight: 3.620 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Intravenous
Reactions Reported:
Seizure NOS Agitation
Outcomes: Outcome Unknown

Dog, ['Retriever - Golden', 'Poodle - Standard'], Male, 7 year, 43.273 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Thrombocytopenia, Blood loss NOS, Skin petechiae, Death • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-074431
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 7.00 Year
  • Weight: 43.273 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Thrombocytopenia Blood loss NOS Skin petechiae Death
Outcomes: Died

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.